文献速递肾移植急性肾损伤

适应性淋巴细胞谱分析区分实体器官移植后轻症与重症COVID-19

Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation.
PubMed 文献 · Kidney Int · 2021-06-11

该回顾性研究比较了实体器官移植受者(72%为肾移植)轻症(WOS 3-4,n=29)与重症(WOS 5-8,n=22)COVID-19的外周血T/B细胞表型及抗体产生。重症者CD3+和CD8+T细胞计数显著降低,活化CD4+T细胞及Treg比例升高,NK细胞比例下降,过渡型B细胞减少;但多数受者仍产生SARS-CoV-2抗体(轻症77%、重症83%)。免疫差异与免疫正常人群报道相似。

要点

  • 重症COVID-19移植受者CD3+和CD8+T细胞计数显著低于轻症者。
  • 重症者活化CD4+T细胞和Treg比例升高,NK细胞比例下降。
  • 过渡型B细胞在重症者中显著减少,但抗体阳转率仍较高。

核心结论

  • 实体器官移植受者轻症与重症COVID-19之间存在免疫学差异,且与免疫正常人群报道相似。

研究设计与样本

  • 回顾性研究,比较29例轻症(WOS 3-4)与22例重症(WOS 5-8)COVID-19的实体器官移植受者(72%为肾移植)。

主要发现

  • 重症者CD3+T细胞计数中位数344/mm3(IQR 197;564) vs 轻症643/mm3(397;1251),显著降低。
  • 重症者CD8+T细胞计数中位数124/mm3(76;229) vs 轻症240/mm3(119;435),显著降低。
  • 重症者活化CD4+T细胞频率2.9%(1.37;5.72) vs 轻症1.4%(0.68;2.35),显著升高。
  • 重症者Treg比例3.9%(2.35;5.87) vs 轻症2.7%(1.9;3.45),显著升高。
  • 重症者过渡型B细胞比例1.2%(0.7;4.2) vs 轻症3.6%(2.1;6.2),显著降低。

关键数值与推荐

  • 轻症定义为WHO 9点序贯量表(WOS)3-4分,重症为WOS 5-8分。
  • 轻症和重症移植受者SARS-CoV-2抗体阳性率分别为77%和83%。

临床怎么用

  • 移植受者COVID-19的免疫表型分析有助于识别重症风险,但需进一步验证。

局限性

  • 回顾性单中心研究,样本量有限(轻症29例、重症22例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Solid organ transplant recipients are at high risk for the development of severe forms of COVID-19. However, the role of immunosuppression in the morbidity and mortality of the immune phenotype during COVID-19 in transplant recipients remains unknown. In this retrospective study, we compared peripheral blood T and B cell functional and surface markers, as well as serum antibody development during 29 cases of mild (World Health Organization 9-point Ordinal Scale (WOS) of 3-4) and 22 cases of severe COVID-19 (WOS 5-8) in solid organ transplant (72% kidney transplant) recipients hospitalized in our center. Patients who developed severe forms of COVID-19 presented significantly lower CD3+ (median 344/mm3 (inter quartile range 197; 564) vs. 643/mm3 (397; 1251)) and CD8+ T cell counts (124/mm3 (76; 229) vs. 240/mm3 (119; 435)). However, activated CD4+ T cells were significantly more frequent in severe forms (2.9% (1.37; 5.72) vs. 1.4% (0.68; 2.35)), counterbalanced by a significantly higher proportion of Tregs (3.9% (2.35; 5.87) vs. 2.7% (1.9; 3.45)). A marked decrease in the proportion of NK cells was noted only in severe forms. In the B cell compartment, transitional B cells were significantly lower in severe forms (1.2% (0.7; 4.2) vs. 3.6% (2.1; 6.2)). Nonetheless, a majority of transplant recipients developed antibodies against SARS-CoV-2 (77% and 83% in mild and severe forms, respectively). Thus, our data revealed immunological differences between mild and severe forms of COVID-19 in solid organ transplant recipients, similar to previous reports in the immunocompetent population.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Del Bello A, Kamar N, Vergez F, et al. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int. 2021. PMID: 34126110. doi:10.1016/j.kint.2021.05.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。